教育干预对社区药剂师多药房管理的影响:中断时间序列分析
Sumire Suzuki1, Tatsuhiko Suzuki2, Tsukasa Kamitani3
1Nanohana Tohoku Co., Ltd., Miyagi 980-0021, Japan.
Annals of clinical epidemiology
|March 9, 2026
概括
社区药房教育改善了药物调整最初的支持要求. 然而,多药房管理干预的长期临床影响是有限的,这表明需要可持续的计划.
科学领域:
- 药房实践 在药房实践中
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 多药房管理是一个重要的公共卫生问题.
- 目前,社区药剂师的干预是有限的.
- 本研究评估了一项以药房为基础的多药房管理教育干预措施.
研究的目的:
- 评估基于社区药房的多药房管理教育干预措施的有效性.
- 分析干预后药物调整支持要求的变化.
主要方法:
- 对从2020年4月到2024年5月的药房索赔数据进行了中断时间序列分析 (ITSA).
- 在2021年6月至9月期间,在404家日本药房实施了教育干预 (讲座,研讨会).
- 主要结果:药物调整支持费2 (FMAS2) 索赔;次要结果:药物调整支持费1 (FMAS1) 索赔.
主要成果:
- 在干预后,FMAS2索赔显著增加,每10万人中有3.82人,p=0.005).
- FMAS1索赔最初增加 (1.29每10万人,p=0.002),但随后下降.
- 对于FMAS2没有观察到显著的趋势变化;对于FMAS1的初始后增加,发现了显著的下降趋势.
结论:
- 教育干预导致药物调整支持索赔的短期增加 (FMAS2和FMAS1).
- 干预的临床影响是温和的,长期有效性有限.
- 未来的战略应优先考虑可持续的多药房管理计划和强大的后续系统.
相关概念视频
Pharmaceutical Poisoning: Potential Scenarios
48
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
48
Drug Dosing: Geriatric Patients
339
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
339
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
781
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
781
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
307
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
307
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
289
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
289
Drug Therapy
360
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
360


